2020 annual financial data
BridgeBio Pharma 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -4,845.61%.
Operating income was -474,482,000 USD and net income was -448,724,000 USD.
Operating cash flow was -399,714,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,249,000 USD
- Operating income
- -474,482,000 USD
- Net income
- -448,724,000 USD
- Operating cash flow
- -399,714,000 USD